The report "Liquid Handling System Market by Type (Automated, Electronic, Manual), Product (Pipettes, Consumables, Accessories, Software), Application (Drug Discovery, Genomics, Diagnostics, Proteomics, Food, Forensic, Environmental), End User, Region - Global Forecasts to 2030 ", is projected to reach USD 7.4 billion by 2030 from USD 5.1 billion in 2025 at a CAGR of 8.0% during the forecast period of 2025 to 2030.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=192124302
The liquid handling system market is expected to witness high growth during the forecast period, mainly driven by the growth of the pharmaceutical and biotechnology industries and the growing R&D spend. Other drivers are increasing focus on data accuracy and precision, as well as growing labor costs.
"The automated systems segment is estimated to dominate the liquid handling system market in 2025."
Based on type, the liquid handling system market is segmented into automated, electronic, and manual systems. The automated liquid handling system segment dominates the market at present. The growth is driven by the widespread use of these systems in pharmaceutical and biotechnology companies, owing to their speed, accuracy, reliability, and consistent performance.
"The drug discovery segment is estimated to account for the largest share of the liquid handling system market in 2025."
Based on the application, the market for liquid handling systems is segmented into drug discovery (high-throughput screening (HTS), compound weighing and dissolution, ADME screening, other drug discovery applications), clinical diagnostics (sample preparation, ELISA, other clinical diagnostics applications), genomics (genotyping, next-generation sequencing (NGS), polymerase chain reaction (PCR), DNA/RNA purification, gene expression analysis, other genomics applications), proteomics, cell and gene therapy, forensic testing, environmental testing (water analysis, waste water analysis, and other environmental testing), food testing, and other applications. Currently, the drug discovery segment holds the largest share of the liquid handling system market. This can be attributed to factors such as increased investment in drug discovery and development, along with the critical roles of sample preparation, assay setup, high-throughput screening, in vitro experiments, cellular assays, and in vivo toxicity studies.
"North America is estimated to account for the largest share of the liquid handling system market in 2025."
Based on the region, the liquid handling system market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is the largest market. The expansion of the North American market for liquid handling systems is fueled by various drivers, including the increase in high-throughput screening, drug discovery, and genomics automation, as well as investments in the life sciences and biotechnology sectors. The scope of clinical diagnostics is also expanding in the region. Furthermore, there is an increase in attention to accuracy and precision when conducting laboratory procedures, combined with ongoing innovation in technologies such as robotics and artificial intelligence, used in liquid handling. The market in North America is also driven by favorable government policies, the presence of large pharmaceutical and biotechnology firms, and an established healthcare infrastructure.
The key players in the liquid handling system market are Thermo Fisher Scientific Inc. (US), Danaher (US), Eppendorf (Germany), PerkinElmer Inc. (US), Agilent Technologies, Inc. (US), Sartorius AG (Germany), Mettler-Toledo International Inc. (US), Qiagen (Netherlands), Corning Incorporated (US), Lonza Group Ltd. (Switzerland), Tecan Group Ltd. (Switzerland), Brooks Automation Inc. (US), Endress+Hauser Group Services AG (Sweden), Brand GmbH & Co. KG (Germany), Greiner Bio-One international GMBH (Germany), Gardner Denver (US), Hamilton Company (US), Gilson Incorporated (US), Hudson Robotics (US), HiTec Zang GMBH (Germany), Integra Biosciences AG (Switzerland), Metrohm A.G (Switzerland), Orochem Technologies Inc. (US), SPT Labtech Ltd. (UK), and Tomtec (US), among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.